FDA approves an Akorn ANDA for an over-the-counter version of GlaxoSmithKlines Flonase (fluticasone propionate) nasal spray USP, 50 mcg per spray, ind...
FDA launches a new tool to alert the public when it becomes aware of ingredients that appear to be unlawfully marketed in dietary supplements the onl...
Federal Register notice: FDA submits to OMB an information collection extension for its Guidance for Industry on Individual Patient Expanded Access Ap...
Federal Register notice: FDA announces a 6/12 public workshop entitled Advancing the Development and Implementation of Analysis Data Standards: Key Ch...
NIH director Francis Collins says a study found that dietary supplements do not extend life for most people in the general population.
CBER director Peter Marks posts an FY 2018 annual report highlighting Center accomplishments including approval of two gene therapies and three vaccin...
FDA Oncology Center of Excellence director Richard Pazdur quizzes cancer immunotherapeutics makers on whether there are too many of their products on ...
FDA grants Advanced Prenatal Therapeutics a breakthrough device designation for its Targeted Apheresis Column for Preeclampsia.